Tandem Meetings 2026
At this year’s Tandem Meetings, taking place 4–7 February 2026, in Salt Lake City, Utah, we are proud to be sharing new data and engaging with the scientific community to drive progress in the care of people living with blood cancers.
You can see the conference program here:
Below is a selection of our abstracts to be presented at this years Tandem Meetings 2026.
Abstract ID
Title / Presenting Author
Room / Date
237
Inpatient Versus Outpatient Administration of CAR T-cell Therapy in relapsed/refractory (R/R) Diffuse Large B-cell Lymphoma (DLBCL): Real-World 30- and 60-Day Costs and Resource Utilization
Presenting Author: Samuel Hong
Room: Poster Hall AB (Salt Palace Convention Center)
Date: Thurs, Feb 5, 2026, 6:30 PM MST
513
Estimating the survival impact of not receiving CAR T-cell (CAR T) therapy when eligible in patients with Relapsed or Refractory (R/R) Diffuse Large B-cell Lymphoma (DLBCL) in the United States (US)
Presenting Author: Frederick Locke
Room: Poster Hall AB (Salt Palace Convention Center)
Date: Thurs, Feb 5, 2026, 6:30 PM MST
269
Systematic Literature Review of Characteristics Associated with Safety and Healthcare Resource Utilization Outcomes in Various Settings of Care for Chimeric Antigen Receptor T-Cell Therapy
Presenting Author: Samuel Hong
Room: Poster Hall AB (Salt Palace Convention Center)
Date: Thurs, Feb 5, 2026, 6:30 PM MST